Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Zomedica Q2 EPS $(0.01) Down From $(0.01) YoY, Sales $6.13M Miss $6.26M Estimate

Author: Benzinga Newsdesk | August 14, 2024 04:50pm
Zomedica (AMEX:ZOM) reported quarterly losses of $(0.01) per share. This is a 100 percent decrease over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $6.13 million which missed the analyst consensus estimate of $6.26 million by 2.06 percent. This is a 1.84 percent increase over sales of $6.02 million the same period last year.

Posted In: ZOM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist